On the Black-White Disparity in Prostate Cancer Mortality

被引：0
作者：
Brawley, Otis W. [1 ,2 ]
Fletcher, Sean A. [3 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] Johns Hopkins Sch Med, Brady Urol Inst, Dept Urol, Baltimore, MD USA
来源：
JNCI CANCER SPECTRUM | 2022年 / 6卷 / 01期
基金：
美国国家卫生研究院;
关键词：
CLINICAL-TRIALS; RACE;
D O I：
10.1093/jncics/pkab094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 18 条
  • [1] Brawley O W, 1995, J Natl Cancer Inst Monogr, P55
  • [2] BRAWLEY OW, 1995, CONTROL CLIN TRIALS, V16, P293, DOI 10.1016/0197-2456(95)00131-X
  • [3] Revisiting Barriers to Clinical Trials Accrual
    Brundage, Michael D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (03): : 219 - 220
  • [4] Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality
    Dess, Robert T.
    Hartman, Holly E.
    Mahal, Brandon A.
    Soni, Payal D.
    Jackson, William C.
    Cooperberg, Matthew R.
    Amling, Christopher L.
    Aronson, William J.
    Kane, Christopher J.
    Terris, Martha K.
    Zumsteg, Zachary S.
    Butler, Santino
    Osborne, Joseph R.
    Morgan, Todd M.
    Mehra, Rohit
    Salami, Simpa S.
    Kishan, Amar U.
    Wang, Chenyang
    Schaeffer, Edward M.
    Roach, Mack, III
    Pisansky, Thomas M.
    Shipley, William U.
    Freedland, Stephen J.
    Sandler, Howard M.
    Halabi, Susan
    Feng, Felix Y.
    Dignam, James J.
    Nguyen, Paul L.
    Schipper, Matthew J.
    Spratt, Daniel E.
    [J]. JAMA ONCOLOGY, 2019, 5 (07) : 975 - 983
  • [5] A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer
    George, Daniel J.
    Halabi, Susan
    Heath, Elisabeth I.
    Sartor, A. Oliver
    Sonpavde, Guru P.
    Das, Devika
    Bitting, Rhonda L.
    Berry, William
    Healy, Patrick
    Anand, Monika
    Winters, Carol
    Riggan, Colleen
    Kephart, Julie
    Wilder, Rhonda
    Shobe, Kellie
    Rasmussen, Julia
    Milowsky, Matthew I.
    Fleming, Mark T.
    Bearden, James
    Goodman, Michael
    Zhang, Tian
    Harrison, Michael R.
    McNamara, Megan
    Zhang, Dadong
    LaCroix, Bonnie L.
    Kittles, Rick A.
    Patierno, Brendon M.
    Sibley, Alexander B.
    Patierno, Steven R.
    Owzar, Kouros
    Hyslop, Terry
    Freedman, Jennifer A.
    Armstrong, Andrew J.
    [J]. CANCER, 2021, 127 (16) : 2954 - 2965
  • [6] QUALITY OF CARE IN THE TREATMENT OF LOCALIZED INTERMEDIATE AND HIGH RISK PROSTATE CANCER AT MINORITY SERVING HOSPITALS
    Krimphove, Marieke Johanna
    Fletcher, Sean Anthony
    Cole, Alexander Putnam
    Berg, Sebastian
    Sun, Maxine
    Lipsitz, Stuart R.
    Mahal, Brandon A.
    Nguyen, Paul L.
    Choueiri, Toni K.
    Kibel, Adam S.
    Kluth, Luis A.
    Weissmann, Joel S.
    Quoc-Dien Trinh
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04) : E599 - E599
  • [7] Racial variation in receipt of quality radiation therapy for prostate cancer
    Lee, Daniel J.
    Zhao, Zhiguo
    Huang, Li-Ching
    Koyoma, Tatsuki
    Resnick, Matthew J.
    Penson, David F.
    Barocas, Daniel A.
    Hoffman, Karen E.
    [J]. CANCER CAUSES & CONTROL, 2018, 29 (10) : 895 - 899
  • [8] Parity and disparity in first course treatment of invasive breast cancer
    Lund, Mary Jo
    Brawley, Otis P.
    Ward, Kevin C.
    Young, John L.
    Gabram, Sheryl S. G.
    Eley, J. William
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 545 - 557
  • [9] McFall SL, 1996, HEALTH SERV RES, V31, P5
  • [10] Active Surveillance for Low-risk Prostate Cancer in African American Men: A Multi-institutional Experience
    Odom, Brian D.
    Mir, M. C.
    Hughes, Scott
    Senechal, Cedric
    Santy, Alexis
    Eyraud, Remi
    Stephenson, Andrew J.
    Ylitalo, Kelly
    Miocinovic, Ranko
    [J]. UROLOGY, 2014, 83 (02) : 364 - 368
12